During a special award ceremony celebrated this week in Santander, in the company of some 400 invited guests from within the scientific, healthcare, and political arenas, the Vall d’Hebron University Hospital’s (HUVH) Hematology Service, directed by Francesc Bosch, received one of this year’s Gaceta Médica’s Best-in-Class (BIC) as the leading national Service for the treatment and care of patients suffering from chronic lymphocytic leukemia (CLL).
Now in their thirteenth annual edition, the BIC awards recognize the best of the best in healthcare provision across various institutions, departments, specialities and disciplines belonging to the Spanish National Healthcare System.
Upon receiving the award and commenting for VHIO Communications, Francesc Bosch – also Principal Investigator of our Experimental Hematology Group – said, “We are very proud to have received this important accolade. Such recognition spurs us yet further to improve outcomes for our patients by identifying more effective and precise treatment strategies as well as advancing novel hemotherapeutics against chronic lymphocytic leukemia and other hematological malignancies.”
Illustrative of VHIO’s purely translational research model, Francesc’s Group is also dedicated to translating preclincial findings into clinical benefit through the development of early phase clinical trials and defining new prognostic and predictive factors. Through their various innovative research lines, Francesc and his team continue to define novel biomarkers towards a more rational and precise treatment of patients.
Serving as further testament to Francesc’s expertise at research level, his team was recently announced as the first Spanish site to conduct a CAR T cell trial against lymphoma. As we revealed earlier this year, VHIO is among one of the 16 selected sites across Europe to participate in the TRANSCEND clinical study for patients with the highly aggressive form of blood cancer, B-cell non-Hodgkin lymphoma (B-Dell NHL). Discover more by reading our dedicated news piece here.
During this week’s BIC ceremony Gaceta Médica also awarded a second program located within the Vall d’Hebron Barcelona Campus. Importantly, the Multiple Sclerosis Centre of Catalonia (CEMCAT), directed by Xavier Montalban, also picked up a BIC prize for its exceptional patient treatment and care aimed at improving the state of health and ensuring the highest possible quality of life for individuals suffering from this chronic and typically progressive disease.
On behalf of VHIO, we congratulate HUVH’s Hematology Service, CEMCAT as well as all the other derserving prize recipients, and salute Gaceta Médica for these important BIC recognitions.
###
